We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Galapagos Candidate Cachexia Drug, GLPG0492, Shows Good Safety and Profile Suitable for Once-Daily Oral Dosing

News   Dec 03, 2010

 
Galapagos Candidate Cachexia Drug, GLPG0492, Shows Good Safety and Profile Suitable for Once-Daily Oral Dosing
 
 
Advertisement
 

RELATED ARTICLES

Improving the Quality and Safety of Heparin

News

A team has analyzed Heparin, the blood-thinning drug, using a new method to that can pinpoint contaminants more accurately and quickly, providing greater quality control and safety.

READ MORE

Preventing Permanent Hearing Loss Caused by Cancer Drug

News

Scientists have identified a receptor that could be inhibited to prevent permanent hearing loss in childhood cancer survivors who are being treated with the drug cisplatin.

READ MORE

Mixing COVID-19 Vaccines Increases Side Effects, Preliminary Data Suggests

News

Leaders of the Com-COV study share preliminary findings that suggest combining different COVID-19 vaccines increases the reactogenicity (side effect profile) associated with vaccination.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE